- Home
- RNXT vs MBOT Comparison
RNXT vs MBOT Comparison
Compare RNXT & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RNXT | MBOT |
|---|---|---|
| Founded | 2012 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.4M | 75.2M |
| IPO Year | 2021 | 2000 |
Fundamental Metrics
Financial Performance| Metric | RNXT | MBOT |
|---|---|---|
| Price | $1.15 | $1.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $7.13 | $6.33 |
| AVG Volume (30 Days) | 547.8K | ★ 619.4K |
| Earning Date | 11-12-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 20.00 | ★ 60.27 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,123,000.00 | $116,887.00 |
| Revenue This Year | $244.84 | N/A |
| Revenue Next Year | $195.26 | $475.55 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2511.63 | N/A |
| 52 Week Low | $0.70 | $1.03 |
| 52 Week High | $2.59 | $3.04 |
Technical Indicators
Market Signals| Indicator | RNXT | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 30.58 | 20.59 |
| Support Level | $0.83 | N/A |
| Resistance Level | $1.28 | $2.21 |
| Average True Range (ATR) | 0.11 | 0.06 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 4.24 | 4.62 |
Price Performance
Historical ComparisonAbout RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.